These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Hepatology; 2004 Jan; 39(1):230-8. PubMed ID: 14752842 [Abstract] [Full Text] [Related]
4. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus. Thuluvath PJ, Maheshwari A, Thuluvath NP, Nguyen GC, Segev DL. Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709 [Abstract] [Full Text] [Related]
5. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. McCashland T, Watt K, Lyden E, Adams L, Charlton M, Smith AD, McGuire BM, Biggins SW, Neff G, Burton JR, Vargas H, Donovan J, Trotter J, Faust T. Liver Transpl; 2007 Sep; 13(9):1246-53. PubMed ID: 17763405 [Abstract] [Full Text] [Related]
6. Liver retransplantation: a single-centre experience. Ma Y, Wang GD, He XS, Li JL. Chin Med J (Engl); 2008 Oct 20; 121(20):1987-91. PubMed ID: 19080261 [Abstract] [Full Text] [Related]
8. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Neff GW, O'Brien CB, Nery J, Shire NJ, Nishida S, delaGarza J, Montalbano M, Safdar K, Ruiz P, Rideman E, Gascon JA, Tzakis AG, Madariaga J, Rudich SM. Liver Transpl; 2004 Dec 20; 10(12):1497-503. PubMed ID: 15558835 [Abstract] [Full Text] [Related]
9. Poor survival after liver retransplantation: is hepatitis C to blame? Watt KD, Lyden ER, McCashland TM. Liver Transpl; 2003 Oct 20; 9(10):1019-24. PubMed ID: 14526394 [Abstract] [Full Text] [Related]
12. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection. Freeman RB. Liver Transpl; 2004 Oct 20; 10(10 Suppl 2):S2-3. PubMed ID: 15382218 [No Abstract] [Full Text] [Related]
13. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, Meyers FJ. Liver Transpl; 2008 Aug 20; 14(8):1100-6. PubMed ID: 18668666 [Abstract] [Full Text] [Related]
15. Impact of model for end-stage liver disease (MELD) scoring system on pathological findings at and after liver transplantation. Khettry U, Azabdaftari G, Simpson MA, Pomfret EA, Pomposelli JJ, Lewis WD, Jenkins RL, Gordon FD. Liver Transpl; 2006 Jun 20; 12(6):958-65. PubMed ID: 16598742 [Abstract] [Full Text] [Related]
17. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Cuomo O, Perrella A, Arenga G. Transplant Proc; 2008 Jun 20; 40(6):1906-9. PubMed ID: 18675085 [Abstract] [Full Text] [Related]
20. Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United States. Burton JR, Rosen HR. Clin Gastroenterol Hepatol; 2005 Jul 20; 3(7):700-4. PubMed ID: 16206504 [Abstract] [Full Text] [Related] Page: [Next] [New Search]